Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #109,951 to #110,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: Patients with Reduced LVEF. Suggest Revisions to the CLASS III Guidelines
  2. The Living Guidelines: Patients with Reduced LVEF. Suggest Revisions to the CLASS IIa Guidelines
  3. The Living Guidelines: Patients with Reduced LVEF. Suggest Revisions to the CLASS IIb Guidelines
  4. The Living Guidelines: Patients with Reduced LVEF. Suggest Revisions to the CLASS I Guidelines
  5. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Polling Results for CLASS III Guidelines
  6. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Polling Results for CLASS IIa Guidelines
  7. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Polling Results for CLASS IIb Guidelines
  8. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Polling Results for CLASS I Guidelines
  9. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Suggest Revisions to the CLASS III Guidelines
  10. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Suggest Revisions to the CLASS IIa Guidelines
  11. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Suggest Revisions to the CLASS IIb Guidelines
  12. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. Suggest Revisions to the CLASS I Guidelines
  13. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS III Guidelines
  14. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIa Guidelines
  15. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIb Guidelines
  16. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS I Guidelines
  17. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS III Guidelines
  18. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS IIa Guidelines
  19. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS IIb Guidelines
  20. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS I Guidelines
  21. The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS III Guidelines
  22. The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS IIa Guidelines
  23. The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS I Guidelines
  24. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS III Guidelines
  25. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS IIa Guidelines
  26. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS I Guidelines
  27. The Living Guidelines: Patients with hyperthyroidism: Polling Results for CLASS I Guidelines
  28. The Living Guidelines: Patients with hyperthyroidism: Suggest Revisions to the CLASS I Guidelines
  29. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS IIa Guidelines
  30. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS I Guidelines
  31. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Suggest Revisions to the CLASS IIa Guidelines
  32. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Suggest Revisions to the CLASS I Guidelines
  33. The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIa Guidelines
  34. The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIb Guidelines
  35. The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS I Guidelines
  36. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIa Guidelines
  37. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIb Guidelines
  38. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS I Guidelines
  39. The Living Guidelines: Percutaneous Coronary Interventions
  40. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS III Guidelines
  41. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS IIa Guidelines
  42. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS IIb Guidelines
  43. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS I Guidelines
  44. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines
  45. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIa Guidelines
  46. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIb Guidelines
  47. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS I Guidelines
  48. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIa Guidelines
  49. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIb Guidelines
  50. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIa Guidelines

View ( | ) (20 | 50 | 100 | 250 | 500)